✦ LIBER ✦

A CONTROLLED TRIAL OF SULPHASALAZINE TREATMENT OF CHRONIC ANKYLOSING SPONDYLITIS: FAILURE TODEMONSTRATE A CLINICAL EFFECT

✍ Scribed by CORKILL, M. M.; JOBANPUTRA, P.; GIBSON, T.; MACFARLANE, D. G.

Book ID: 127220074
Publisher: Oxford University Press
Year: 1990
Tongue: English
Weight: 425 KB
Volume: 29
Category: Article
ISSN: 1462-0324
DOI: 10.1093/rheumatology/29.1.41

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of aquatic exercise on ankylosing

Effect of aquatic exercise on ankylosing spondylitis: a randomized controlled trial

✍ Dundar, U.; Solak, O.; Toktas, H.; Demirdal, U. S.; Subasi, V.; Kavuncu, V.; Evc 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 196 KB

Treatment of active ankylosing spondylit

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

✍ J Braun; J Brandt; J Listing; A Zink; R Alten; W Golder; E Gromnica-lhle; H Kell 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 107 KB

Cost effectiveness of combined spa-exerc

Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: A randomized controlled trial

✍ Van Tubergen, Astrid ;Boonen, Annelies ;Landewé, Robert ;Rutten-Van Mölken, Maur 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Milrinone in the treatment of chronic ca

Milrinone in the treatment of chronic cardiac failure: A controlled trial

✍ Mariell J. Likoff; Karl T. Weber; Virginia Andrews; Joseph S. Janicki; Hugh Wils 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 889 KB

Anti-interleukin-17A monoclonal antibody

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

✍ Baeten, Dominique; Baraliakos, Xenofon; Braun, Jürgen; Sieper, Joachim; Emery, P 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 780 KB

Six-month results of a double-blind, pla

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. Sörensen; L. Grassnickel; M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFα therapy with etanercept, a 75‐kd recepto